US NIH authorizes first uses for genomic data from HeLa cells
A US NIH working group approved the first four projects looking to use genomic data from the infamous HeLa cell line.
A US NIH working group approved the first four projects looking to use genomic data from the infamous HeLa cell line.
Kemwell says it intends to open the Indian market to contract biomanufacturing as it signs its first monoclonal antibody (mAb) development and manufacture agreement for a European biopharma.
The US Department of Health and Human Services (HHS) says it is buying cell lines to manufacture anthrax antitoxins on top of its $196m (€145m) deal with GlaxoSmithKline to stockpile Raxibacumab.